Christopher M. O’Connor

Active 1980–2025

Also published as
Christopher M. O'Connor
350
Papers
73,435
Citations
146
h-index
347
i10-index

Citations

Citations per year for Christopher M. O’Connor1971: 1 citations1981: 2 citations1984: 3 citations1985: 2 citations1986: 2 citations1987: 3 citations1988: 5 citations1989: 8 citations1990: 6 citations1991: 8 citations1992: 12 citations1993: 4 citations1994: 4 citations1995: 4 citations1996: 12 citations1997: 20 citations1998: 46 citations1999: 49 citations2000: 64 citations2001: 82 citations2002: 122 citations2003: 182 citations2004: 230 citations2005: 347 citations2006: 326 citations2007: 328 citations2008: 403 citations2009: 490 citations2010: 552 citations2011: 474 citations2012: 580 citations2013: 647 citations2014: 476 citations2015: 550 citations2016: 547 citations2017: 531 citations2018: 464 citations2019: 1,846 citations2020: 1,773 citations2021: 1,871 citations2022: 1,605 citations2023: 1,187 citations2024: 1,882 citations2025: 939 citations2026: 23 citations1972–1980: no citations, so these years are not shown1982–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,335 citing papers, 25.6% of this breakdownUnited Kingdom: 1,766 citing papers, 7.1% of this breakdownItaly: 1,553 citing papers, 6.3% of this breakdownGermany: 1,341 citing papers, 5.4% of this breakdownCanada: 1,272 citing papers, 5.1% of this breakdownNetherlands: 1,098 citing papers, 4.4% of this breakdownChina: 905 citing papers, 3.7% of this breakdownFrance: 882 citing papers, 3.6% of this breakdownJapan: 665 citing papers, 2.7% of this breakdownSpain: 641 citing papers, 2.6% of this breakdownAustralia: 584 citing papers, 2.4% of this breakdownSweden: 577 citing papers, 2.3% of this breakdown
0%25.6%Other 28.8%

Fields

  • Medicine85%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Engineering3.2%
  • Immunology and Microbiology1.3%
  • Neuroscience1.1%
  • Health Professions0.9%
  • Other3.4%

Topics

  • Heart Failure Treatment and Management12.5%
  • Cardiovascular Function and Risk Factors7.5%
  • Cardiac Health and Mental Health3.5%
  • Cardiac pacing and defibrillation studies2.6%
  • Acute Myocardial Infarction Research2.4%
  • Cardiovascular and exercise physiology2.2%
  • Other69.3%

Coauthors

All papers

Open in search
  1. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,299

  2. Interventions for Frailty Among Older Adults With Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 395

  3. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple - Circulation 2018 cited by 713

  4. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 547

  5. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2009 cited by 2,167

  6. Diuretic Strategies in Patients with Acute Decompensated Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,692

  7. Standardized Team-Based Care for Cardiogenic Shock

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 505

  8. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 984

  9. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the RELAX Trial - JAMA 2013 cited by 1,130

  10. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 275

  11. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness

    Authors: , , , , , , , , , - JAMA 2005 cited by 1,520

  12. Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,293

  13. Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , - JAMA 2017 cited by 538

  14. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 cited by 322

  15. Palliative Care in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 598

  16. Clinical Implications of the New York Heart Association Classification

    Authors: , , , , , , , , , , , , - Journal of the American Heart Association 2019 cited by 337

  17. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2022 cited by 118

  18. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2007 cited by 1,091

  19. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure

    Authors: , , , , , , , , , , , , , , , - International Journal of Cardiology 2018 cited by 291

  20. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

    Authors: , , , , , , , , , , , , , , , - Journal of Cardiac Failure 2020 cited by 101

  21. Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 541

  22. Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 272

  23. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients

    Authors: , , , , , , , , , - Journal of the American Heart Association 2018 cited by 245

  24. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury

    Authors: , , , , , , , , , , , , , - Circulation 2018 cited by 350